BioNano Genomics (formerly BioNanomatrix) is the developer of the nanoAnalyzer SystemŽ platform, which provides medical researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged and interact with each other. The company is supported by grants from genomics programs at such agencies as the NIH and NIST-ATP and works with institutions in life science, translational research, molecular diagnostics and personalized medicine. In 2010 Medical Device and Diagnostic Industry named the company as one of 50 companies to watch. General Partner Tracy Warren is Board chairman.
Company news and select media highlights
Company Web Site
http://www.bionanogenomics.com/
|
